FBLG

FibroBiologics, Inc. Common Stock

NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY

$1.24

+2.90% today

Updated 2026-10-02

Market cap

$9.67M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.10

Dividend yield

—

52W range

$1 – $12

Volume

0.2M

Market cap

$9.67M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.10

Dividend yield

—

52W range

$1 – $12

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-12.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →265 stocks currently score above 75

Price targets

Analyst target

$12.50

+908.06%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.32x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -12.57 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.29M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-5.12M	$-16.48M	$-11.16M	$-18.65M	$-4.12M
EPS	—	—	—	—	$-5.10
Free cash flow	$-4.07M	$-6.90M	$-12.09M	$-16.66M	$-3.29M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FBLG	$9.67M	23	4.3	3.0	5.0	5.5	—	Avoid
LLY	$1.03T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$648.67B	59	4.7	8.5	2.7	5.5	-89.24%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.03%	Strong Buy
MRK	$365.34B	36	4.0	4.5	2.0	5.0	-74.53%	Hold
UNH	$333.27B	62	7.3	5.5	5.3	5.5	-11.87%	Buy

Smart narrative

FibroBiologics, Inc. Common Stock trades at $1.24. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -12.57, it sits in the distress.

Frequently asked questions

What is FibroBiologics, Inc. Common Stock's stock price?

FibroBiologics, Inc. Common Stock (FBLG) trades at $1.24.

Is FibroBiologics, Inc. Common Stock overvalued?

FibroBiologics, Inc. Common Stock carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of FibroBiologics, Inc. Common Stock (FBLG)?

The 12-month analyst consensus target is $12.50, about 908.1% above the current $1.24. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

FibroBiologics, Inc. Common Stock's Altman Z-Score is -12.57, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-718.46%

Beta1.68

50D MA$1.21

200D MA$2.99

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

FBLG vs LLY →FBLG vs JNJ →FBLG vs ABBV →Stock screener →